FDA updates talazoparib and enzalutamide labeling, confirming survival benefits for HRR-mutated mCRPC, while excluding ...

Dr. Sara M. Tolaney breaks down key takeaways from the DESTINY-Breast09 trial that patients with HER2+ advanced or metastatic ...

Scientists uncover surprising immune response that helps tumors grow, revealing new strategies to improve treatment ...

Christopher Gregg has lived years beyond what his oncologists originally accepted. Lessons from farming may have helped.

Cancer plasticity allows tumor cells to change their identity, evade therapies, and adapt to environmental pressures, contributing to treatment resistance and metastasis. New research is targeting ...